Page 2 - Chief Science News Today

CARLSBAD, Calif., April 26, 2024 -- Exagen Inc. , a leading provider of autoimmune testing solutions, today announced changes to the Board of Directors. Exagen is pleased to announce Scott Kahn,...

BELLEVUE, Wash.--(BUSINESS WIRE)--Apr 23, 2024--

Offering Diverse Perspectives on Science and Medicine

The conversation around state-level proposals that seek to ban certain FDA-approved food additives has been filled with myths pushed by unqualified voices and lacking facts presented by those with scientific expertise in the fields of food safety and toxicology. This prompts the question: What are the qualified experts saying?

Novocure today announced 20 presentations on Tumor Treating Fields therapy will be delivered at the American Association for Cancer Research Annual Meeting 2024, to be held April 5 to 10 in San...

TORONTO, April 02, 2024 -- Arch Biopartners Inc., , announced today that three additional clinical sites in Turkey have joined the Phase II trial for LSALT peptide targeting the prevention and...

Scientists created a highly accurate reference genome for one of the most important modern crops and found a rare example of how genes confer disease resistance

Scientists created a highly accurate reference genome for one of the most important modern crops and found a rare example of how genes confer disease resistance

Marvel Biosciences Corp. , and its wholly owned subsidiary, Marvel Biotechnology Inc. , today reported promising interim results from its acute study on MB-204 conducted by Professor Emmanuel Planel...

Marvel Biosciences Corp. , and its wholly owned subsidiary, Marvel Biotechnology Inc. , today reported promising interim results from its study on MB-204, a new treatment for autism, conducted by the...